Walsh Kieran Anthony, O'Riordan David, Kearney Patricia M, Timmons Suzanne, Byrne Stephen
Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland Department of Epidemiology and Public Health, University College Cork, Cork, Ireland.
Department of Epidemiology and Public Health, University College Cork, Cork, Ireland.
Age Ageing. 2016 Mar;45(2):201-9. doi: 10.1093/ageing/afv190. Epub 2016 Jan 10.
potentially inappropriate prescribing (PIP) in older hospitalised patients, and in particular those with dementia, is associated with poorer health outcomes. PIP reduction is therefore essential in this population.
a comprehensive electronic literature search was conducted using 12 databases from inception up to and including September 2014. Inclusion criteria were controlled trials (randomised or non-randomised) of interventions involving pharmacists conducted in hospitals, with an objective of the study being PIP reduction in patients 65 years or older or patients with dementia of any age, using any validated PIP tool as an outcome measure. Risk of bias assessments were conducted utilising the Cochrane Collaboration's tool.
a total of 1,752 records were found after duplicates were removed. Four trials (n = 1,164 patients; two randomised, two non-randomised) from three countries were included in the quantitative analysis. All studies were at moderate risk of bias. No study focused specifically on dementia patients. Three trials reported statistically significant reductions in the Medication Appropriateness Index score in the intervention group (mean difference from admission to discharge = -7.45, 95% CI: -11.14, -3.76) and other PIP tools such as Beers Criteria. One trial reported reduced drug-related readmissions and another reported increased adverse drug reactions.
multi-disciplinary teams involving pharmacists may improve prescribing appropriateness in older inpatients, though the clinical significance of observed reductions is unclear. More research is required into the effectiveness of pharmacists' interventions in reducing PIP in dementia patients. Additionally, easily assessed and clinically relevant measures of PIP need to be developed.
老年住院患者,尤其是患有痴呆症的患者,潜在不适当用药(PIP)与较差的健康结局相关。因此,减少这一人群的PIP至关重要。
使用12个数据库进行全面的电子文献检索,检索时间从数据库建立至2014年9月(含)。纳入标准为在医院进行的涉及药剂师的干预措施的对照试验(随机或非随机),研究目的是降低65岁及以上患者或任何年龄痴呆症患者的PIP,使用任何经过验证的PIP工具作为结局指标。使用Cochrane协作网的工具进行偏倚风险评估。
去除重复记录后共找到1752条记录。对来自三个国家的四项试验(n = 1164例患者;两项随机试验,两项非随机试验)进行了定量分析。所有研究的偏倚风险均为中度。没有研究专门针对痴呆症患者。三项试验报告干预组的用药适宜性指数得分有统计学显著降低(入院至出院的平均差值 = -7.45, 95% CI: -11.14, -3.76)以及其他PIP工具如Beers标准得分降低。一项试验报告药物相关再入院率降低,另一项试验报告药物不良反应增加。
涉及药剂师的多学科团队可能会改善老年住院患者的用药适宜性,尽管观察到的降低的临床意义尚不清楚。需要更多研究来探讨药剂师干预对降低痴呆症患者PIP的有效性。此外,需要开发易于评估且与临床相关的PIP测量方法。